Scientists Grab $11 Million to Study AstraZeneca PLC's Failed Drugs

Published: Nov 01, 2012

British academic researchers have secured 7 million pounds ($11 million) of funding from the country's Medical Research Council (MRC) to investigate a range of potential new drugs made available free-of-charge by AstraZeneca.

The move is the latest example of how the pharmaceutical industry is experimenting with new research models involving greater collaboration with external partners.

Back to news